PT  - JOURNAL ARTICLE
AU  - J A Casas
AU  - C P Subauste
AU  - G S Alarcón
TI  - A new promising treatment in systemic sclerosis: 5-fluorouracil.
AID  - 10.1136/ard.46.10.763
DP  - 1987 Oct 01
TA  - Annals of the Rheumatic Diseases
PG  - 763--767
VI  - 46
IP  - 10
4099  - http://ard.bmj.com/content/46/10/763.short
4100  - http://ard.bmj.com/content/46/10/763.full
SO  - Ann Rheum Dis1987 Oct 01; 46
AB  - Twelve patients with systemic sclerosis according to American Rheumatism Association criteria were treated with intravenous 5-fluorouracil. Significant subjective and objective improvement occurred initially in the skin and subsequently in the involved viscera and vasculature. These preliminary results suggest that 5-fluorouracil may be an effective treatment for systemic sclerosis.